HIV-1 Virus Impact Factor
In the course of 30 years since the discovery of HIV as the causative agent of
AIDS we have made remarkable progress in understanding the biology and
pathogenesis of the virus and the field of viral dynamics has been critical for understanding the details of progression of HIV
infection to AIDS. A typical primary
infection is characterized by high levels of viral titers in plasma with concomitant decrease in the CD4+ T cell numbers. At the end of primary
infection stage the viral titers decline due to depletion of CD4+ T
cells and partial immune activation. Few months later the virus enters the chronic stage typified by a slow increase in the viral titers and gradual decrease in the CD4+ T cell levels, immune activation, increased cell turnover and destruction of host immune system. The
impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing
journals of similar kind. It reflects the average number of citations to recent
articles published in science and
social science journals in a particular year or period, and is frequently used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founder of the Institute for Scientific Information.
High Impact List of Articles
-
Factors associated with adherence to diet and exercise among type 2 diabetes patients in Yemen
Abdullah Alhariri*, Faiz Daud & Sultan Ayesh Mohammed Saghir
Research Article: Diabetes Management
-
Factors associated with adherence to diet and exercise among type 2 diabetes patients in Yemen
Abdullah Alhariri*, Faiz Daud & Sultan Ayesh Mohammed Saghir
Research Article: Diabetes Management
-
Effectiveness and safety of basal-bolus therapy (insulin glargine+insulin glulisine) in patients with type 1 diabetes previously uncontrolled on any insulin regimen: multinational phase-IV study
Boudiba A, Al-Arouj M, Robertson LI, Chantelot JM, Al-Rubeaan KA & Charpentier G*
Research Article: Diabetes Management
-
Effectiveness and safety of basal-bolus therapy (insulin glargine+insulin glulisine) in patients with type 1 diabetes previously uncontrolled on any insulin regimen: multinational phase-IV study
Boudiba A, Al-Arouj M, Robertson LI, Chantelot JM, Al-Rubeaan KA & Charpentier G*
Research Article: Diabetes Management
-
Feeding behavior of patients with type 2 diabetes living at Cotonou, Benin
Alassani A, Dovonou Ac, Gninkoun J, Wanvoegbe A, Azandjeme C, Jerome S, Attinsounon A, Gomina M, Mizehoun AC, Codjo L, Ade S, Amoussou-Guenou D & Djrolo F
Research Article: Diabetes Management
-
Feeding behavior of patients with type 2 diabetes living at Cotonou, Benin
Alassani A, Dovonou Ac, Gninkoun J, Wanvoegbe A, Azandjeme C, Jerome S, Attinsounon A, Gomina M, Mizehoun AC, Codjo L, Ade S, Amoussou-Guenou D & Djrolo F
Research Article: Diabetes Management
-
Canagliflozin for Type 2 diabetes: an up-to-date evidence summary
Aris Liakos, Thomas Karagiannis, Eleni Bekiari & Apostolos Tsapas
Review Article: Diabetes Management
-
Canagliflozin for Type 2 diabetes: an up-to-date evidence summary
Aris Liakos, Thomas Karagiannis, Eleni Bekiari & Apostolos Tsapas
Review Article: Diabetes Management
-
A comparison of US treatment guidelines for Type 2 diabetes mellitus: applications to the newly diagnosed patient
Lisa M Chastain, Megan Stapleton & Jill Frost
Perspective: Diabetes Management
-
A comparison of US treatment guidelines for Type 2 diabetes mellitus: applications to the newly diagnosed patient
Lisa M Chastain, Megan Stapleton & Jill Frost
Perspective: Diabetes Management
-
Blockade of the renin-angiotensin system for the primary prevention of diabetic nephropathy
Merlin C Thomas & Robert MacGinley
Review Article: Diabetes Management
-
Blockade of the renin-angiotensin system for the primary prevention of diabetic nephropathy
Merlin C Thomas & Robert MacGinley
Review Article: Diabetes Management
Relevant Topics in Clinical